Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
NDUFA1 (HGNC:7683) encodes the MWFE subunit of mitochondrial complex I. Leigh syndrome (MONDO:0009723) is a progressive neurodegenerative disorder of childhood. To date, two unrelated male patients hemizygous for NDUFA1 missense variants have been reported. One infant presented with atypical spinal cord involvement on MRI due to an unidentified hemizygous NDUFA1 mutation ((PMID:29506883)) and a second patient harbored c.55C>T (p.Pro19Ser), confirmed as pathogenic in cybrid assays ((PMID:25356405)). Conversely, a screen of 152 complex I–deficient patients, including Leigh syndrome cases, did not identify additional NDUFA1 mutations, indicating these alleles are rare ((PMID:11286378)). Clinical hallmarks include seizures, increased CSF lactate, and failure to thrive ((PMID:24731534)).
Functional studies demonstrate that p.Pro19Ser markedly reduces complex I activity in cybrid and patient fibroblast assays ((PMID:25356405)). An X-linked Ndufa1^S55A^ mouse model recapitulates systemic partial complex I deficiency with age-dependent neurodegeneration, supporting a loss-of-function mechanism ((PMID:28506826)). No studies to date have refuted the NDUFA1–Leigh syndrome link beyond the absence of common variants. Together, genetic and experimental data support a Limited level of clinical validity for X-linked recessive NDUFA1 deficiency in Leigh syndrome. Key take-home: hemizygous pathogenic missense variants in NDUFA1 cause partial complex I deficiency manifesting as Leigh syndrome, guiding molecular diagnosis and genetic counseling.
Gene–Disease AssociationLimitedTwo unrelated hemizygous missense cases with functional confirmation and negative screening in 152 patients (PMID:11286378) Genetic EvidenceLimited2 probands with X-linked hemizygous missense variants; no segregation data; absence of additional alleles in 152 cases (PMID:11286378) Functional EvidenceModerateCybrid assays confirm reduced complex I activity for p.Pro19Ser (PMID:25356405); mouse model replicates neurodegeneration (PMID:28506826) |